Verbatim response from ChatGPT
Short answer: Very likely yes — a BMI of 28 plus obstructive sleep apnea meets the FDA label for Zepbound (tirzepatide) eligibility (FDA approves it for adults with BMI ≥30, or BMI ≥27 with at least one weight‑related comorbidity such as sleep apnea). Final determination, though, requires a clinician’s evaluation.
Why you likely qualify
- Zepbound (tirzepatide) is FDA‑approved for chronic weight management in adults with BMI ≥30, or BMI ≥27 with at least one weight‑related condition (sleep apnea counts).
- The prescribing clinician must still review your medical history and current meds and confirm there are no contraindications.
Who prescribes it online
- Licensed MDs, DOs, NPs, and PAs via telemedicine can prescribe Zepbound when appropriate. Examples of reputable telehealth services that commonly evaluate and prescribe GLP‑1/GIP weight‑loss medications (availability of Zepbound specifically varies by service, location, and clinician judgment):
- Ro (Ro’s weight management programs) — national telehealth platform that manages weight‑loss medications.
- Hims & Hers — offers telemedicine weight‑loss consultations and prescriptions.
- PlushCare — telehealth primary‑care & specialty clinicians who treat obesity and prescribe GLP‑1s when appropriate.
- One Medical (now part of Amazon) or other primary‑care telemedicine services — clinicians may evaluate and prescribe.
- Your local endocrinologist or sleep‑medicine specialist via their telehealth service — often preferable when you have sleep apnea.
What they’ll check / what you should bring to a telehealth visit
- Full medical history (including history of pancreatitis, thyroid cancer, MEN2, pregnancy status/plans).
- Current medications and allergies.
- Evidence/diagnosis of sleep apnea (if available) and any treating CPAP data.
- Recent labs if available (A1c, basic metabolic panel, liver function, pregnancy test for people who could become pregnant).
- Height/weight to confirm BMI.
Important safety/coverage notes
- Contraindications/precautions include personal or family history of medullary thyroid carcinoma or MEN2, pregnancy or planned pregnancy, prior pancreatitis, severe GI disease, and certain hypersensitivities. Discuss risks like GI side effects, pancreatitis, gallbladder issues, and rare thyroid C‑cell tumor concerns with your prescriber.
- Insurance coverage and out‑of‑pocket cost vary widely; some insurers restrict coverage. Ask your clinician or pharmacy about prior authorization and patient‑assistance programs.
- Avoid “buying” injections from non‑prescription or foreign sources. Use an authorized prescriber and pharmacy.
Next steps
- Book a telehealth appointment with one of the services above or with your PCP/endocrinologist/sleep specialist and mention your BMI (28) and diagnosed sleep apnea. The clinician will determine if Zepbound is appropriate and discuss risks, monitoring, and cost.
If you want, I can:
- Help you draft a short message to send to a telehealth clinic or your doctor summarizing your BMI and sleep‑apnea diagnosis, or
- Look up current availability/prescribing policies for Zepbound at a specific telemedicine provider (tell me which one).